NDC 0591-2136-55 - Propofol
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0591-2136
- Requested NDC
- 0591-2136-55
- Package NDCs from labels
- 0591-2136-55, 0591-2136-51, 0591-2136-57, 0591-2136-68, 0591-2136-80, 0591-2136-95
- Manufacturer
- Actavis Pharma, Inc.
- Effective date
- 2023-05-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Propofol - Actavis Pharma, Inc. | Actavis Pharma, Inc. | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - Henry Schein, Inc. | Henry Schein, Inc. | 2022-01-13 | HUMAN PRESCRIPTION DRUG LABEL |
| PROPOFOL - General Injectables & Vaccines, Inc. | General Injectables & Vaccines, Inc. | 2021-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol - A-S Medication Solutions | A-S Medication Solutions | 2021-04-15 | HUMAN PRESCRIPTION DRUG LABEL |
| Propofol | General Injectables and Vaccines, Inc. | 2018-04-19 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0591-2136-51 | ML - Milliliter | 0591-2136 | 0b14f2f2-28a4-4fb5-a669-08abd4efc03a | 1 | 2016-02-04 |
| 0591-2136-55 | ML - Milliliter | 0591-2136 | c7340b05-171e-42b9-9aaa-f4423b6cba5b | 1 | 2016-02-04 |
| 0591-2136-57 | ML - Milliliter | 0591-2136 | 20f74f85-7313-40e5-a1bd-99d35d50d3cd | 1 | 2016-02-04 |
| 0591-2136-68 | ML - Milliliter | 0591-2136 | 47d8a6dd-b9a7-457a-a1e8-e8e835d9157a | 1 | 2016-02-04 |
| 0591-2136-80 | ML - Milliliter | 0591-2136 | ecc8f542-06b4-4ab8-8638-70de2da9f8bd | 1 | 2016-02-04 |
| 0591-2136-95 | ML - Milliliter | 0591-2136 | 0d8814c1-098b-4f9e-8b00-4e25f3db5dc8 | 1 | 2016-02-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 740e0a3b-b9a0-4012-80f6-2d34691c1188 | 475de1f2-9b88-455a-ba3c-48e96083c056 | 2025-09-16 | Warnings, Adverse reactions | 475de1f2-9b88-455a-ba3c-48e96083c056 | ||
| Perikabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | c2eb5522-8572-45f4-869d-42f9fd251bb6 | 2025-09-15 | Warnings, Adverse reactions | 241ATL177A |
| REFRESH OPTIVE Drops | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 80275190-d717-40ea-905b-5c8fbe986eac | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva PF Xtra | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | b51b8a75-8faa-430f-8f7e-ee58d3d13f2e | 2025-09-15 | Warnings | PDC6A3C0OX |
| Refresh Relieva | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 6b984fa2-4187-45ef-b7d3-15e720abc667 | 2025-09-15 | Warnings | PDC6A3C0OX |
| Oasis Tears PF Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 640f95f4-c2e8-48ad-ad40-f76bbaddb0dc | 2025-09-12 | Warnings | PDC6A3C0OX |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | e3105799-a4b6-f3f4-e6e2-b2b29bbdb538 | 2025-09-11 | Warnings, Adverse reactions | YI7VU623SF |
| Kabiven | DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE | Fresenius Kabi USA, LLC | afeb4837-a759-4484-a76e-e04611c459e7 | 2025-09-11 | Warnings, Adverse reactions | 241ATL177A |
| Diprivan | PROPOFOL | Fresenius Kabi USA, LLC | fee3bd4a-ade3-41fa-839a-48e9af69bcf4 | 2025-09-10 | Warnings, Adverse reactions | YI7VU623SF |
| Oasis TEARS PF PLUS Preservative-Free Lubricant Eye | GLYCERIN | OASIS Medical, Inc. | 5d080191-423d-4c0a-b5ae-2ccf5c4a67cb | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin | GLYCERIN | Rising Pharma Holdings, Inc. | db539b39-9504-44d2-9bd5-ba6ffb441024 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Glycerin Children | GLYCERIN | Rising Pharma Holdings, Inc. | 80a5a944-2882-4f8d-a955-ef827cead5f0 | 2025-09-08 | Warnings | PDC6A3C0OX |
| Foaming Facial Cleanser | GLYCERIN, NIACINAMIDE | Guangzhou Danting Bath&Body Care Industry Co. Ltd | 396c1db9-a5d3-cc82-e063-6294a90a90bb | 2025-08-23 | Warnings | PDC6A3C0OX |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | PDC6A3C0OX |
| Upside Down Pain Relief | BENZOCAINE, GLYCERIN | Fridababy, LLC | 31c2cd25-1fec-5ec5-e063-6394a90a24b4 | 2025-08-15 | Warnings | PDC6A3C0OX |
| Smoflipid | SMOFLIPID | Fresenius Kabi USA, LLC | e0e9d917-ff6f-488e-a6a8-0ad59dd17d80 | 2025-08-15 | Warnings, Adverse reactions | 241ATL177A |
| Norms Hemorrhoid | GLYCERIN, LIDOCAINE, PETROLATUM, PHENYLEPHRINE HCL | Totally Normal Company | 3bdf8c74-3db6-1805-e063-6394a90aaba0 | 2025-08-08 | Warnings | PDC6A3C0OX |
| Durma DynaGel | DURMA DYNAGEL | Dynarex Corporation | 3bcbe314-98ca-78f1-e063-6394a90a13ad | 2025-08-07 | Warnings | PDC6A3C0OX |
| Medics Choice Fresh and Soothe | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Unimed | 3bcd8394-f486-d306-e063-6294a90a4e9a | 2025-08-07 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.